TRIDENT LIFELINE
Back to Cashflow Statement
|
TRIDENT LIFELINE Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-10 Cr | ₹2.23 Cr | ₹-19 Cr | ₹-0.21 Cr |
What is the latest Cash Flow from Operating Activities ratio of TRIDENT LIFELINE ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-10 Cr |
| Mar2024 | ₹2.23 Cr |
| Mar2023 | ₹-19 Cr |
| Mar2022 | ₹-0.21 Cr |
How is Cash Flow from Operating Activities of TRIDENT LIFELINE Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-10 Cr | Negative | |
| Mar2024 | ₹2.23 Cr | Positive | |
| Mar2023 | ₹-19 Cr | Negative | |
| Mar2022 | ₹-0.21 Cr | - | |
Compare Cash Flow from Operating Activities of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹309.6 Cr | 0.5% | 7.1% | -12.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | 0.5% |
7.1% |
-12.3% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses